Morten Andersen

10.0k total citations · 2 hit papers
211 papers, 6.6k citations indexed

About

Morten Andersen is a scholar working on Economics and Econometrics, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Morten Andersen has authored 211 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Economics and Econometrics, 33 papers in Surgery and 32 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Morten Andersen's work include Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Practices and Patient Outcomes (20 papers) and Pharmaceutical Economics and Policy (19 papers). Morten Andersen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Practices and Patient Outcomes (20 papers) and Pharmaceutical Economics and Policy (19 papers). Morten Andersen collaborates with scholars based in Denmark, Sweden and Norway. Morten Andersen's co-authors include Jesper Hallas, Jakob Kragstrup, Björn Wettermark, Henrik Toft Sørensen, Mette Klarskov Andersen, Kari Furu, Jens Søndergaard, Anna Birna Almarsdóttir, Jaana E. Martikainen and Lars Bjerrum and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Morten Andersen

205 papers receiving 6.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

2021 266 citations Anton Pottegård, Lars Christian Lund et al. profile →
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

2021 163 citations Morten Andersen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Morten Andersen	1.1k	1.1k	997	898	756	211	6.6k
Ken Farrington	1.4k 1.3×	616 0.6×	865 0.9×	692 0.8×	496 0.7×	252	7.0k
Anton Pottegård	1.3k 1.1×	1.5k 1.4×	1.1k 1.1×	944 1.1×	1.1k 1.5×	385	10.0k
K. Arnold Chan	1.8k 1.6×	1.2k 1.1×	1.1k 1.1×	995 1.1×	632 0.8×	210	10.4k
Edeltraut Garbe	804 0.7×	1.1k 1.0×	617 0.6×	469 0.5×	805 1.1×	174	6.9k
Alexander M. Walker	2.0k 1.8×	1.3k 1.2×	1.5k 1.5×	1.3k 1.4×	1.1k 1.4×	206	11.9k
Suetonia C. Palmer	1.7k 1.5×	1.6k 1.5×	1.1k 1.1×	623 0.7×	731 1.0×	215	10.7k
Robert S. Epstein	1.8k 1.6×	786 0.7×	543 0.5×	1.4k 1.6×	735 1.0×	103	8.7k
David T. Gilbertson	1.9k 1.7×	1.4k 1.4×	939 0.9×	737 0.8×	620 0.8×	180	10.2k
Ron M. C. Herings	1.5k 1.3×	1.2k 1.1×	518 0.5×	717 0.8×	803 1.1×	247	8.4k
David W. Kaufman	1.5k 1.3×	973 0.9×	1.7k 1.7×	319 0.4×	365 0.5×	178	11.1k

Countries citing papers authored by Morten Andersen

Since Specialization

Citations

This map shows the geographic impact of Morten Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Andersen more than expected).

Fields of papers citing papers by Morten Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Andersen. The network helps show where Morten Andersen may publish in the future.

Co-authorship network of co-authors of Morten Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Andersen. A scholar is included among the top collaborators of Morten Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Andersen. Morten Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gräf, Débora Dalmas, et al.. (2025). Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants. Drug Safety. 49(4). 493–503.

HALLBERG, A., Morten Andersen, Elisabeth A. Pedersen, et al.. (2025). Epidemiological outcomes and policy implementation in the Nordic countries during the COVID-19 pandemic. Archives of Public Health. 83(1). 46–46. 3 indexed citations

Andersen, Morten, et al.. (2025). Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022. Drug Safety. 48(7). 781–794. 1 indexed citations

Hansen, Torben Frøstrup, Lars Henrik Jensen, Claus Lohman Brasen, et al.. (2024). A Bayesian Network Approach to Lung Cancer Screening: Assessing the Impact of Data Quantity, Quality, and the Combination of Data from Danish Electronic Health Records. Cancers. 16(23). 3989–3989.

Pedersen, Elisabeth, Huiqi Li, Anna Cantarutti, et al.. (2024). Drug utilisation in children and adolescents before and after the start of the COVID‐19 pandemic: Interrupted time‐series analyses in three European countries. Paediatric and Perinatal Epidemiology. 38(6). 450–460. 4 indexed citations

Lund, Lars Christian, et al.. (2023). Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis. Diabetes Obesity and Metabolism. 25(5). 1311–1320. 7 indexed citations

Andersen, Morten, et al.. (2023). AI-based disease risk score for community-acquired pneumonia hospitalization. iScience. 26(7). 107027–107027. 4 indexed citations

Nyberg, Fredrik, Huiqi Li, Hedvig Nordeng, et al.. (2023). Artificial intelligence-driven prediction of COVID-19-related hospitalization and death: a systematic review. Frontiers in Public Health. 11. 1183725–1183725. 14 indexed citations

Lund, Lars Christian, Henrik Støvring, Anton Pottegård, Morten Andersen, & Jesper Hallas. (2023). Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety. Journal of Clinical Epidemiology. 156. 127–136. 11 indexed citations

10.

Bruin, Marie L. De, et al.. (2023). Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data. Basic & Clinical Pharmacology & Toxicology. 134(1). 129–140. 1 indexed citations

11.

Jakobsen, Lasse Hjort, Torbjörn Callréus, Maurizio Sessa, et al.. (2021). Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma. Pharmacoepidemiology and Drug Safety. 30(4). 514–519. 2 indexed citations

12.

Ham, H. R., Patrick C. Souverein, Olaf H. Klungel, et al.. (2019). Risk of major bleeding associated with the use of individual direct oral anticoagulants compared to vitamin K antagonists in patients with non-valvular atrial fibrillation: a meta-analysis of results from multiple population-based cohort studies using a common protocol in Europe and Canada. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations

13.

Callréus, Torbjörn, Tarec Christoffer El‐Galaly, Mats Jerkeman, Peter de Nully Brown, & Morten Andersen. (2019). Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases. Pharmaceutical Medicine. 33(2). 83–88. 2 indexed citations

14.

Andersen, Morten, et al.. (2019). The Gemini Fast Turnaround program. 233. 1 indexed citations

15.

Taipale, Heidi, Johan Reutfors, Anna Westerlund, et al.. (2018). Initiation and long‐term use of benzodiazepines and Z‐drugs in bipolar disorder. Bipolar Disorders. 20(7). 634–646. 23 indexed citations

16.

Gaudet, Daniel, Julie Méthot, Diane Brisson, et al.. (2016). A Long-Term (up to 6 years) Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and its Effect on Lipoprotein Lipase Deficiency (LPLD)-Induced Pancreatitis.. Human Gene Therapy. 2 indexed citations

17.

Lykkegaard, Jesper, Jesper Rømhild Davidsen, Maja Skov Paulsen, Morten Andersen, & Jens Søndergaard. (2012). On the crest of a wave: Danish prevalence of hospitalisation-required COPD 2002–2009. Respiratory Medicine. 106(10). 1396–1403. 4 indexed citations

18.

Lykkegaard, Jesper, et al.. (2011). All Danish first-time COPD hospitalisations 2002–2008: Incidence, outcome, patients, and care. Respiratory Medicine. 106(4). 549–556. 18 indexed citations

19.

Gülmez, Sinem Ezgi, Annmarie Touborg Lassen, Claus Aalykke, et al.. (2008). Spironolactone use and the risk of upper gastrointestinal bleeding: a population‐based case–control study. British Journal of Clinical Pharmacology. 66(2). 294–299. 23 indexed citations

20.

Tsiropoulos, Ioannis, Anthony Gichangi, Morten Andersen, et al.. (2006). Trends in utilization of antiepileptic drugs in Denmark. Acta Neurologica Scandinavica. 113(6). 405–411. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact